{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:53:42Z","timestamp":1787007222314,"version":"build-2736575974"},"reference-count":64,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2020,10,2]]},"DOI":"10.1080\/14712598.2020.1776254","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T20:22:38Z","timestamp":1590697358000},"page":"1215-1222","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Anti-CD6 mAbs for the treatment of psoriasis"],"prefix":"10.1080","volume":"20","author":[{"given":"Sunil","family":"Dogra","sequence":"first","affiliation":[{"name":"Venereology, and Leprology, Postgraduate Institute of Medical Education & Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabeer","family":"D","sequence":"additional","affiliation":[{"name":"Biocon Biologics","place":["Bangalore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murlidhar","family":"Rajagopalan","sequence":"additional","affiliation":[{"name":"Apollo Hospital","place":["Chennai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S64950"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.12.001"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.72443"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5015"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.039"},{"key":"e_1_3_4_7_1","volume-title":"Dermatology","author":"van de Kerkhof PCM","year":"2012","unstructured":"van de Kerkhof PCM, Nestle FO. Psoriasis. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. Amsterdam: Elsevier; 2012."},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-4-35"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20165374"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.53175"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000475519"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/130646"},{"issue":"14","key":"e_1_3_4_13_1","first-page":"1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand JM","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA Dermatol. 2006;296(14):1735\u20131741.","journal-title":"JAMA Dermatol"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.09020.x"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03318.x"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2010.02310.x"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.2502"},{"issue":"8","key":"e_1_3_4_18_1","first-page":"843","article-title":"Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis","volume":"10","author":"Han C","year":"2011","unstructured":"Han C, Lofland JH, Zhao N, et al. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis. J Drugs Dermatol. 2011;10(8): 843\u2013850. [PubMed: 21818505].","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.115532"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.28376"},{"issue":"7","key":"e_1_3_4_21_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.4103\/0378-6323.115505","article-title":"Pathophysiology of psoriasis","volume":"79","author":"Mahajan R","year":"2013","unstructured":"Mahajan R, Handa S. Pathophysiology of psoriasis. Indian J Dermatol Venereol Leprol. 2013;79(Suppl 7):S1\u2013S9.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804595"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80440-9"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05154.x"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2007.04.005"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S154073"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.058"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.897"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916939908995386"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar450"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.6.777"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.19.6047"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0004(94)90165-1"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/153685903322328974"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/hyb.2008.0007"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02602784"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002510000235"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2001.00961.x"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.08.008"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxf025"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2262"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rinim.2012.11.001"},{"key":"e_1_3_4_44_1","unstructured":"AlzumabTM(Itolizumab) solution for iv infusion [prescribing information]. India: Biocon Inc.;2013 [cited 2019 Dec 3]. Available from: http:\/\/www.biocon.com\/docs\/prescribing_information\/immunotherapy\/alzumab_pi.pdf"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-013-8423-x"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04235.x"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.184.Supp.96.13"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.040"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12509"},{"issue":"3","key":"e_1_3_4_50_1","first-page":"257","article-title":"Itolizumab humanized monoclonal antibody (anti-cd6) in patients with cd6+ lymphoproliferative disorders. Preliminary experience","volume":"30","author":"Cano LM","year":"2014","unstructured":"Cano LM, Estrada EE, Hern\u00e1ndez Padr\u00f3n C, et al. Itolizumab humanized monoclonal antibody (anti-cd6) in patients with cd6+ lymphoproliferative disorders. Preliminary experience. Revista Cubana de Hematol Inmunol y Hemoter. 2014;30(3):257\u2013264.","journal-title":"Revista Cubana de Hematol Inmunol y Hemoter"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.12.006"},{"issue":"3","key":"e_1_3_4_52_1","first-page":"413","article-title":"Use of Itolizumab in chronic plaque psoriasis patients: clinical experience","volume":"3","author":"Nott A","year":"2016","unstructured":"Nott A, Raghavan V, Sashidharan N. Use of Itolizumab in chronic plaque psoriasis patients: clinical experience. Ejpmr. 2016;3(3):413\u2013416.","journal-title":"Ejpmr"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_330_16"},{"issue":"11","key":"e_1_3_4_54_1","first-page":"WD01","article-title":"Safety and efficacy of itolizumab in the treatment of psoriasis: a case series of 20 patients","volume":"10","author":"Parthasaradhi A","year":"2016","unstructured":"Parthasaradhi A. Safety and efficacy of itolizumab in the treatment of psoriasis: a case series of 20 patients. J Clin Diagn Res. 2016;10(11):WD01\u2013WD03.","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"e_1_3_4_55_1","first-page":"12","article-title":"Itolizumab as the first line of treatment in moderate to severe chronic plaque posriasis: a case report","volume":"9","author":"Trasi S","year":"2016","unstructured":"Trasi S, Sashidharan N. Itolizumab as the first line of treatment in moderate to severe chronic plaque posriasis: a case report. Asian J Pharm Clin Res. 2016;9(2):12.","journal-title":"Asian J Pharm Clin Res"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.181466"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.115506"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1316326"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100626"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615253114"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_519_18"},{"key":"e_1_3_4_62_1","unstructured":"A Study of Itolizumab (EQ001) to Evaluate the Safety Tolerability PK PD and Clinical Activity in Uncontrolled Asthma (EQUIP). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04007198"},{"key":"e_1_3_4_63_1","unstructured":"Available from: https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=646718"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.198765"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.3456"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2020.1776254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:31:34Z","timestamp":1770406294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2020.1776254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,2]]}},"alternative-id":["10.1080\/14712598.2020.1776254"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2020.1776254","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}